參考文獻/References:
[1] CHEN S J,LIN C S,LIN C L,et al.Osteoporosis is associ-ated with high risk for coronary heart disease:A Population-based Cohort Study[J].Medicine(Baltimore),2015,94(27):e1146.
[2] LEE S N,CHO J Y,EUN Y M,et al.Associations between osteoporosis and coronary artery disease in postmenopausal women[J].Climacteric,2016,19(5):458-462.
[3] 祁慧萌,趙心,王爽,等.中老年骨質(zhì)疏松與下肢動脈粥樣硬化相關(guān)性分析[J].中華實用診斷與治療雜志,2016,30(5):478-480.
[4] MIN H,MORONY S,SAROSI I,et al.Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis[J].J Exp Med,2000,192(4):463-474.
[5] ORITA Y,YAMAMOTO H,KOHNO N,et al.Role of osteoprotegerin in arterial calcification development of new animal model[J].Arterioscler Thromb Vasc Biol,2007,27(9):2058-2064.
[6] CALLEGARI A,COONS M L,RICKS J L,et al.Increased calcification in osteoprotegerin-deficient smooth muscle cells:Dependence on receptor activator of NF-κB ligand and interleukin 6[J].J Vasc Res,2014,51(2):118-131.
[7] WINKLER D G,SUTHERLAND M K,GEOGHEGAN J C,et al.Osteocyte control of bone formation via sclerostin,a novel BMP antagonist[J].EMBO J,2003,22(23):6267-6276.
[8] 張樹東,祝孟海,李世飛,等.骨硬化蛋白與骨質(zhì)疏松:治療的新方向[J].中國組織工程研究,2017,21(36):5847-5854.
[9] 劉蕾,張樹儉,徐曉娜,等.腹膜透析患者血清骨硬化蛋白與冠狀動脈鈣化及骨密度的關(guān)系[J].中國中西醫(yī)結(jié)合腎病雜志,2018,19(7):592-595.
[10] KOOS R,BRANDENBURG V,MAHNKEN A H,et al.Sclerostin as a potential novel biomarker for aortic valve calcification:an in-vivo and ex-vivo study[J].J Heart Valve Dis,2013,22(3):317-325.
[11] 位艷偉,柳達,付平,等.血清鐵蛋白與血清鐵調(diào)素在老年原發(fā)性高血壓合并骨質(zhì)疏松中作用的研究[J].中國骨質(zhì)疏松雜志,2018,24(1):87-90.
[12] 孫瑞華.冠心病患者血清鐵蛋白、總鐵結(jié)合力、血清鐵蛋白/總鐵結(jié)合力水平與冠狀動脈病變及心血管事件的關(guān)系[J].中國衛(wèi)生檢驗雜志,2017,27(13):1897-1899.
[13] 張迪暉,黃澤鑫,羅斌.體檢女性血清鐵蛋白與骨密度的關(guān)系[J].中國醫(yī)藥導(dǎo)報,2018,15(25):75-78.
[14] 經(jīng)保生,賈鵬,陸政峰,等.唑來膦酸治療椎體骨質(zhì)疏松的療效與鐵蓄積的相關(guān)性[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2018,11(2):126-130.
[15] CHON S J,CHOI Y R,ROH Y H,et al.Association between levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women:KNHANES 2008-2010[J].PLoS One,2014,9(12):e114972.
[16] FELDBRIN Z,LUCKISH A,SHARGORODSKY M.Effects of long-term risedronate treatment on serum ferritin levels in postmenopausal women with osteoporosis:the impact of cardiovascular risk factor load[J].Menopause,2016,23(1):55-59.
[17] 童雪影,唐祖勝,陳敏,等.骨橋蛋白的增齡性變化對骨質(zhì)疏松癥的影響[J].中國老年保健醫(yī)學,2015,13(4):42-43.
[18] LUNA-LUNA M,CRUZ-ROBLES D,áVILA-VANZZINI N,et al.Differential expression of osteopontin,and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis:association with HDL subclasses[J].Lipids Health Dis,2017,16(1):156.
[19] 王和鳴,黃桂成.中醫(yī)骨傷科學[M].3版.北京:中國中醫(yī)藥出版社,2013:373-374.
[20] 陳志強,楊關(guān)林.中西醫(yī)結(jié)合內(nèi)科學[M].3版.北京:中國中醫(yī)藥出版社,2018:175.
[21] 王永炎,常富業(yè),楊寶琴.病絡(luò)與絡(luò)病對比研究[J].北京中醫(yī)藥大學學報,2005,28(3):1-6.
[22] 邱瑞瑾,高永紅,商洪才,等.病絡(luò)理論指導(dǎo)下腦、心、腎一體化中西醫(yī)結(jié)合防治體系的構(gòu)建[J].中醫(yī)雜志,2016,57(5):361-365.
[23] 李紅梅,王婧文,孫曉婷,等.絡(luò)風內(nèi)動與動脈粥樣硬化斑塊內(nèi)血管新生[J].中醫(yī)雜志,2017,58(17):1462-1465.
[24] 何偉.心肺系疾病繼發(fā)骨質(zhì)疏松癥的病絡(luò)機制及科學內(nèi)涵[J].中國骨質(zhì)疏松雜志,2018,24(9):1241-1245.
[25] 榮杰,許穎智,張軍平.冠心病患者介入術(shù)前后中醫(yī)證候演變規(guī)律分析[J].中醫(yī)雜志,2012,53(23):2027-2030.
[26] 漆仲文,王曉景,仲愛芹,等.基于育心保脈理論調(diào)治冠心病危險因素[J].中醫(yī)雜志,2017,58(14):1192-1195.
[27] 韓秀文,王進.心腎相交理論對治療骨質(zhì)疏松癥指導(dǎo)作用的研究[J].湖北中醫(yī)雜志,2011,33(6):32-33.
[28] 朱偉慧,張力.老年人骨質(zhì)疏松與頸動脈硬化間的相關(guān)性分析及干預(yù)策略[J].中國老年學雜志,2015,35(23):6869-6871.
[29] 汪弢,盧輝和,盛臻強,等.骨質(zhì)疏松癥與冠狀動脈病變嚴重程度的相關(guān)性分析[J].中國現(xiàn)代醫(yī)學雜志,2018,28(6):118-121.
相似文獻/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[3]李學朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):12.
[4]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[5]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):27.
[6]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):19.
[7]項旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):20.
[8]史曉林,李春雯,張志強.弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):5.
[9]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):21.
[10]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(08):16.